Manulife Financial Corporation filed an underwriting agreement dated September 1, 2026, proposing to issue and sell 6.146% Subordinated Notes due 2041. The offering is conducted pursuant to a shelf registration statement on Form F-10 (Registration No. 333-290499) with BofA Securities, Citigroup, J.P. Morgan, and Morgan Stanley acting as representatives. This debt issuance allows the company to raise capital for general corporate purposes under its existing regulatory framework in Canada and the United States. Manulife Financial Corporation operates in the global insurance and financial services industry.

Manulife Financial Corporation priced a U.S. public offering of $750,000,000 aggregate principal amount of 6.146% subordinated notes due 2041 at par (100.000%). The notes are anticipated to qualify as Tier 2 regulatory capital and will bear interest at a fixed annual rate until September 11, 2036, after which the rate resets based on the CMT Rate plus 1.350%. Issuance is expected on September 11, 2026, with net proceeds designated for general corporate purposes, including potential refinancing. BofA Securities, Citigroup, J.P. Morgan, and Morgan Stanley are acting as joint book-running managers. Manulife Financial Corporation operates in the international financial services industry, providing insurance, health solutions, and asset management across Canada, Asia, and the United States.

Manulife Financial Corporation announced an interest rate reset on its Limited Recourse Capital Notes Series 1. The company is a global financial services provider offering insurance, wealth management, and asset management services.